AIm: Sulfadiazine (SD) is a classic antibiotic for intracranial infection. Due to the medical market policy, SD has not been chosen as an essential drug in all the hospitals in China. However, its therapeutic effect is definite and cannot be substituted. The aim of this study was to evaluate the therapeutic and economic value of SD compared to other popular antibiotics in patients with refractory intracranial infection. mAterIAl and methOds: A retrospective single-center study was performed from January 2011 until December 2012. Thirteen patients diagnosed with refractory intracranial infection were treated with SD. The clinical effects were reviewed. results: Treatment was successful for 12 of the patients (cure rate=92.3%). One patient died of secondary epilepsy, respiratory complications, and multiple organ failure. Only one patient was allergic to SD, and there were no drug-related liver or kidney side effects.
INTRODUCTION
Intracranial infection is a common postoperative complication in neurosurgical patients. It is a significant problem worldwide and results in substantial morbidity/mortality if not treated quickly and vigorously (6).
Significantly varied rates of intracranial infection have been reported, ranging from 0.72 to >8% (7, 11), depending on antibiotic prophylaxis, diverse periods in which the surveys were conducted, as well as different countries in which the studies were conducted. Despite a dramatic increase in technological advancement in neurosurgical and postoperative care, the intracranial infection rate following neurosurgeries has not decreased as much as expected in recent decades. Indeed, it has been suggested that the actual incidence of intracranial infection s is even higher than that reported (9). Although many methods have been used to prevent these infections, the rate of occurrence is still very high.
Sulfadiazine (SD) used to be a classical antibiotic for treatment of intracranial infections in China and worldwide, with a broad antibiogram. It is effective for most gram-positive and gramnegative bacterial infections. However, nowadays the use of SD is mainly confined to treatment of partial-thickness and mid-dermal burn, and toxoplasmic encephalitis (1, 3, 4, 10, 14) .
A good preoperative assessment, a successful surgery, effective postoperative management, and most importantly, an effective and economical antibiotic are necessary for the prevention of intracranial infection. We retrospectively reviewed 13 cases of refractory intracranial infection that were treated with SD. Information on the clinical data, the therapeutic results, and the side effects were available for all of the patients. We defined refractory intracranial infection as the inability to control infection after routine antiinflammatory treatments, including empirical antimicrobial therapy, external ventricular drainage, and/or cisterna cerebellomedullaris drainage.
PATIENTS and METHODS
Thirteen patients with intracranial lesions were treated surgically between January 2011 and December 2012 at the Department of Neurosurgery, Shanghai Changzheng Hospital, China. Every patient developed refractory intracranial infection after surgery. Demographic data, data on infectious predisposing factors, anatomical location of the lesion, and microbiology results were obtained from electronic hospital data forms for all of the patients ( Table I ). The director of our department made the decision to treat the patients with sulfadiazine. This was an observational study and all care was decided by the attending physician with no involvement of the researchers. Written approval was obtained from the ethics committee of Shanghai Second Military Medical University for this study. A written consent in accordance with the ethical committee standards was given to and signed by participating patients (by post or outpatient follow-up). The consent obtained for patients that died was signed by the same clientele as their duration of hospital stay.
Medical Regimen
As soon as the diagnosis of intracranial infection was confirmed, empirical antimicrobial therapy was initiated.
Our initial empirical antimicrobial therapy included a combination of vancomycin and ceftriaxone. If the infection was not controlled within 3 to 5 days, we chose linezolid and meropenem, or changed to more targeted antibiotics as soon as the results of sensitivity tests were available. At the same time, intrathecal injections of gentamycin (4-8 mg) or vancomycin (20 mg) were given every day. If the intracranial infection was not controlled after these treatments, we treated with SD (sodium). SD (0.4 g/2 ml) was purchased from the Shanghai Modern "Harson" Pharmacology Company (Shanghai, China). A druguse written consent was signed by patients or their legal guardians. The first dose was 50 mg/kg, followed by 1600 mg IV every 6 h. During treatment, we monitored clinical manifestations, temperature, blood routine test, cerebrospinal fluid (CSF), and, if necessary, modified the dose. The largest dose was 150 mg/kg. Body temperature was usually normal after 3-7 days treatment, and the CSF gradually cleared. A course of SD treatment was 7-20 days, with an average of 15 days. Oral sulfamethoxazole (0.96 g, BID) was then given after the IV treatment. The entire course of antibiotic therapy was 4-8 weeks, depending on the therapeutic response. Infectious disease specialists regularly supervised the treatments.
RESULTS
The 13 patients were 7 males and 6 females, with an average age of 49.6 years (range 15-69 years). All the patients received external ventricular or lumbar catheters (continuous drainage) before or after the intracranial infection. Some of the causes of the infections were catheter-related, some were related to the surgery, and some were from CSF leakage through the incision. Treatment was successful for 12 of the patients (cure rate=92.3%). One patient died of secondary epilepsy, respiratory complications, and multiple organ failure. Only one patient was allergic to SD, and there were no drug-related liver or kidney side effects.
Clinical Manifestation
Fever is the most obvious symptom, followed by rigor and meningeal irritation. Routine blood tests showed a white blood cell (WBC) count greater than 10×10 9 /L in all 13 cases, in which 5 cases were greater than 20×10 9 /L. Over 80% of neutrophilic granulocytes were observed in all cases. All patients received a blood culture if the temperature reached 38.5 °C or the patients had rigor. However, only one patient had a positive result in a blood culture: Staphylococcus epidermidis.
A CSF examination was performed on all patients, which included examinations of pressure, appearance, biochemistry, culture, and drug sensitivity. The CSF pressure ranged from 250 to 400 mm H 2 O. The appearance was turbid, like rice water, or even with flocculent pus. The WBC count in the CSF was greater than 400×10 6 /L in 10 cases and equal to 400×10 6 /L in 3 cases. The biochemistry results of the CSF showed a positive Pandy test. Glu was between 0.1 and 2.0 mM. CSF culture and drug sensitivity tests showed that four patients had the same broad spectrum-resistant bacterial infection in at least two successive tests: Acinetobacter baumannii, Stenotrophomonas maltophilia, Flavobacterium indologenes and Klebsiella pneumoniae, respectively. In one patient, a culture of both the lateral ventricle catheter and the CSF yielded Sphingomonas paucimobilis. However, a subsequent CSF culture test yielded positive results for Pseudomonas fluorescens and fragrant Flavobacterium. One case was positive for Enterobacter cloacae, whereas the others were negative.
Illustrative Cases
One patient was a female, 61 years in age, with a fourth ventricle epidermoid cyst. Her state of consciousness became severely affected on the fifth day after surgery. The head CT scan revealed obstructive hydrocephalus, and emergency external ventricular drainage was performed. A definitive diagnosis of intracranial infection was made on the third day when a high fever developed, which was accompanied by turbid CSF. Continuous external ventricular drainage and anti-inflammation therapy were initiated. The patient then developed status epilepticus. After anti-epileptic therapy, the patient's state of consciousness worsened, so a tracheotomy was performed. She also developed bipolar pneumonia. SD and Sulperazon (cefoperazone + sulbactam) were given, which controlled the intracranial infection and pneumonia. However, the patient died from multiple organ dysfunction syndrome (MODS).
One patient was a male, 55 years in age, with a left trigeminal neurinoma. After surgery, he recovered without complications.
Ten days after surgery, the sutures were removed from the suboccipital incision. The upper part of the incision appeared to be leaking cerebrospinal fluid after a severe cough during the night. The next day, the patient was hyperpyrexic, with a temperature=40°C. Vancomycin and ceftriaxone sodium were given, and cisterna cerebellomedullaris drainage was performed. The infection was not controlled, so we changed to SD therapy. Routine blood tests and the CSF returned to normal, but the temperature fluctuated. A test for a fungal infection was negative. A small dose of dexamethasone was added, and the temperature returned to normal.
DISCUSSION
Dubey et al. (2) reported that CSF leaks were most frequently encountered in 13% of posterior cranial fossa surgery patients, followed by meningitis (9.2%) and wound infection (7%), which are consistent with our findings and other reports (5). In a large scale retrospective survey in Chinese population, Zhan et al. (15) drew the conclusion that CSF leakage, CSF drainage of any kind, subsequent short term surgery, and surgery duration were major risk factors of postoperative intracranial infection, indicating that surgery-focused management might be the most effective way to minimize the risk for central nervous system infection after cranial surgery.
To prevent postoperative infection, our neurosurgical department advocates appropriate use of prophylactic antibiotics. In general, a broad-spectrum antibiotic, usually a second generation cephalosporin, is administered 30 minutes before surgery. If the surgery exceeds 4 hours in length, or the volume of blood loss exceeds 1 L, and additional dose is given. Standard sterile techniques, meticulous wound closure, and proper wound care after surgery also minimize the risk of intracranial infection. When postoperative infection does occur, attention is commonly focused on potential lapses in surgical "sterility".
Evidence suggests that the surgical field is not free of microorganisms (8). Walcott et al. (13) proposed a paradigm shift in the nomenclature of the surgical field from "sterile" to "clean. " Continued efforts aimed at optimizing immune capacity and host defenses to combat potential infection are warranted.
SD should be used when routine antibiotics are not effective or when financial considerations are an issue. Not all of China's citizens are covered by health insurance. Different proportions of a patient's cost of hospitalization are reimbursed, and these proportions are lower for patients from rural areas. Therefore, economic factors must be considered when the clinician chooses the therapeutic schedule. Fortunately, SD controls the infection and, at the same time, relieves the economic burden. Table II presents a combination of daptomycin at 10 mg/kg daily plus trimethoprim/sulfamethoxazole (TMP/SMX). They concluded that combination of high-dose daptomycin plus TMP/SMX is a reasonable option for treatment of meningitis caused by multidrug-resistant S. epidermidis. In our study, four patients had the same broad spectrum-resistant bacterial infection in at least two successive tests, which were all successfully cured by SD.
Due to medical market policy, SD has not been chosen for the essential drug catalog in almost all of the hospitals in China. But, it has a definite therapeutic effect and there are no appropriate substitutes. SD is a classical antibiotic for treatment of intracranial infections. When injected, SD is widely distributed in whole body tissue and humour (e.g., pleural fluid, peritoneal fluid, synovial fluid, aqueous humor). It also penetrates the blood-brain barrier. The drug concentration of SD in CSF is 50% of that in blood without meningitis. However, the drug concentration increases to 50-80% with meningitis. It also easily penetrates fetal blood circulation. The elimination half life of SD is 10 hours with normal kidney function and is 34 hours in patients with kidney failure. SD (60-85%) is discharged in the urine in the form of the drug prototype after 48-72 h. The protein binding rate is 38-48%.
As a result of our experience on SD, we have several recommendations to treat refractory intracranial infections. The initial dose should be large, especially for treatment of cases with a positive CSF culture test. The recommended initial dose is 50 mg/kg, followed by 1600 mg, q 6 h, in order to ensure that a sufficient blood drug concentration is achieved after passing blood brain barrier. The course of treatment should be long, and sequential therapy is strongly recommended. SD is a safe, effective, well-tolerated, and classical antibiotic for the treatment of intracranial infection.
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